Ahmad A. Tarhini

Also affiliated with Advanced Dermatology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 44 papers. Top paper: “Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134”.

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Journal of Clinical Oncology(2022)10.1200/jco.22.01763

N/A

5.4DataRank · unranked

446 citations

Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach‐Giao Truong +31 more

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-Oncology(2021)10.1093/neuonc/noab094

N/A

4.0DataRank · unranked

126 citations

Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid +18 more

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

Journal of Translational Medicine(2022)10.1186/s12967-022-03450-3

N/A

0.614DataRank · unranked

12 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +10 more

Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0177

N/A

0.170DataRank · unranked

2 citations

Rebecca Hoyd, Ayse S. Yilmaz, Jiangjiang Zhu, YunZhou Liu, Malvenderjit S. Jagjit Singh +31 more

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22078

N/A

0DataRank · unranked

1 citations

Yue Zheng, Sandra J. Lee, F. Stephen Hodi, UMA RAO, Gary I. Cohen +4 more

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22090

N/A

0DataRank · unranked

0 citations

Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, UMA RAO, Vernon K. Sondak +2 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0DataRank · unranked

102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

Early Cortisol and Inflammatory Responses to Parental Cancer and Their Impact on Functional Impairment in Youth

Journal of Clinical Medicine(2021)10.3390/jcm10040576

N/A

0DataRank · unranked

2 citations

Jacob Brent, Yongqi Zhong, Shervin Bazmi, Giovanna Porta, Dana H. Bovbjerg +6 more

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.36_suppl.356154

N/A

0DataRank · unranked

111 citations

Sandra J. Lee, Bartosz Chmielowski, Antoni Ribas, Ahmad A. Tarhini, Thach‐Giao Truong +9 more

Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9501

N/A

0DataRank · unranked

18 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Teresa M. Petrella +15 more

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade adjuvant therapy: An analysis of 1670 high-risk patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9582

N/A

0DataRank · unranked

1 citations

Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood +5 more

88 Evidence of enhanced immune activation within the tumor microenvironment and the circulation of female patients with high-risk melanoma compared to males

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.088

N/A

0DataRank · unranked

1 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +9 more

1073P Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1458

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Megan Othus, Amy K. Darke, Ahmad A. Tarhini, John M. Kirkwood +5 more

87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.087

N/A

0DataRank · unranked

0 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +8 more

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma

Molecular Carcinogenesis(2022)10.1002/mc.23442

N/A

0DataRank · unranked

22 citations

Mengyu Xie, Ahmad A. Tarhini, Aik Choon Tan, Samuel S. Coleman

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004310

N/A

0DataRank · unranked

19 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +9 more

IFx-Hu2.0 phase I first in human study for unresectable melanoma for an intralesional “in-situ vaccine” approach.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21542

N/A

0DataRank · unranked

6 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +7 more

Early quality of life (QOL) and symptom analysis from the DREAMseq phase III randomized control trial of combination immunotherapy versus targeted therapy in patients (pts) with BRAF-mutant metastatic melanoma (MM) (ECOG-ACRIN EA6134).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9559

N/A

0DataRank · unranked

2 citations

Yue Zheng, Michael B. Atkins, Bartosz Chmielowski, Ahmad A. Tarhini, Thach‐Giao Truong +14 more

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers(2023)10.3390/cancers15092561

N/A

0DataRank · unranked

13 citations

Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus +7 more

PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing

BMC Bioinformatics(2023)10.1186/s12859-023-05393-y

N/A

0DataRank · unranked

9 citations

Darwin Chang, Gabrielle Nobles, Mingxiang Teng, Aik Choon Tan, Xuefeng Wang +9 more

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.24.542123

N/A

0DataRank · unranked

5 citations

Samuel S. Coleman, Rebecca Hoyd, Louis Denko, Carlos H.F. Chan, Michelle L. Churchman +19 more

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.24.541982

N/A

0DataRank · unranked

3 citations

Anjun Ma, Megan E. McNutt, Rebecca Hoyd, Caroline E. Wheeler, Lary A. Robinson +24 more

The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.01.555936

N/A

0DataRank · unranked

2 citations

Rebecca Hoyd, McKenzie Kreamer, Caroline E. Wheeler, Dennis J. Grencewicz, Fouad Choueiry +27 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

A Lasso Cox score consisting of CTLA4+ regulatory T cells (Treg), monocytic myeloid derived suppressor cells (M-MDSC), and CXCR3+ CD8+ T cells: Association with adjuvant ipilimumab (ipi) survival outcomes in patients (pts) with high-risk melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21557

N/A

0DataRank · unranked

0 citations

Timothy I. Shaw, Sandra J. Lee, F. Stephen Hodi, Patrick Hwu, Dung‐Tsa Chen +7 more

Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

Immunity(2024)10.1016/j.immuni.2024.03.020

N/A

0DataRank · unranked

33 citations

Rosa A. Sierra-Mondragon, Rachel V. Jimenez, Darwin Chang, Eslam Mohamed, Shiun Chang +23 more

The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0367

N/A

0DataRank · unranked

24 citations

Rebecca Hoyd, McKenzie Kreamer, Caroline E. Wheeler, Dennis J. Grencewicz, Fouad Choueiry +27 more

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2768

N/A

0DataRank · unranked

11 citations

Zeynep Eroglu, Islam Eljilany, Jonathan S. Zager, R. Gonzalez, Amod A. Sarnaik +13 more

First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0652

N/A

0DataRank · unranked

9 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +13 more

A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0213

N/A

0DataRank · unranked

7 citations

Anjun Ma, Yingjie Li, Megan E. McNutt, Shiqi Zhang, Jiangjiang Zhu +27 more

Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers

Journal of Oncology Research and Therapy(2024)10.29011/2574-710x.10224

N/A

0DataRank · unranked

1 citations

Dale J. Hedges, Aik Choon Tan, Paulo C. Rodrı́guez, Vineeth Sukrithan, Aakrosh Ratan +10 more

Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.17.613509

N/A

0DataRank · unranked

2 citations

Anthony Rojas, Rebecca G. Zitnay, Keith R. Carney, Wakeiyo Hettinga, Mary C. Schaelling +18 more

Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010153

N/A

0DataRank · unranked

10 citations

Lourdes Plaza-Rojas, Justin C. Boucher, Elena V. Kostenko, Anna L Austin, Ahmad A. Tarhini +9 more

Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

Nature Communications(2025)10.1038/s41467-025-65016-3

N/A

0DataRank · unranked

5 citations

Tingyi Li, Islam Eljilany, Alex C. Soupir, Michael D. Radmacher, Phaedra Agius +17 more

Overall side‐effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

Cancer(2025)10.1002/cncr.70084

N/A

0DataRank · unranked

2 citations

Shaili Ganatra, Fengmin Zhao, Ju‐Whei Lee, Jessica Roydhouse, Edward H. Ip +13 more

Primary tumor microbiomes predict distant metastasis of colorectal cancer

npj Precision Oncology(2025)10.1038/s41698-025-01188-x

N/A

0DataRank · unranked

1 citations

Vishal Midya, Ryan Kiddle, Nicola De Jager, Shoshannah Eggers, Daniel Spakowicz +21 more

Primary tumor microbiomes predict distant metastasis of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.02.654060

N/A

0DataRank · unranked

1 citations

Vishal Midya, Ryan Kiddle, Nicola De Jager, Shoshannah Eggers, Daniel Spakowicz +21 more

Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry

Lasers in Surgery and Medicine(2020)10.1002/lsm.23286

N/A

0DataRank · unranked

19 citations

Ahmad A. Tarhini, Cindy Sander, Martin E. Sanders, Justin Cook, John A. Viator +1 more

1695eP Systematic evaluation of polygenic risk scores (PRS) for autoimmune thyroid disease and the risk of thyroiditis following checkpoint immunotherapy (ICI) of melanoma in a North American patient (pt) population

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2322

N/A

0DataRank · unranked

0 citations

Zhihua Chen, Seok-Joo Lee, F.S. Hodi, Yuying Li, Howard Streicher +5 more

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines

UNC Libraries(2020)10.17615/nf2z-7x04

N/A

0DataRank · unranked

1 citations

Ahmad A. Tarhini, Joe Marc Chauvin, Stergios J. Moschos, Ornella Pagliano, Cindy Sander +12 more

Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19132

N/A

0DataRank · unranked

3 citations

John Devin Peipert, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +15 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.60

N/A

0DataRank · unranked

1 citations

Sandra J. Lee, Ni Kang, F. Stephen Hodi, Uma N. M. Rao, Gary I. Cohen +5 more